0000899243-20-021047.txt : 20200803 0000899243-20-021047.hdr.sgml : 20200803 20200803210919 ACCESSION NUMBER: 0000899243-20-021047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200730 FILED AS OF DATE: 20200803 DATE AS OF CHANGE: 20200803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAY RUSSELL T CENTRAL INDEX KEY: 0001225960 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35409 FILM NUMBER: 201070756 MAIL ADDRESS: STREET 1: 2525 DUPONT DR CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERRIMACK PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001274792 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-441-1000 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-30 0 0001274792 MERRIMACK PHARMACEUTICALS INC MACK 0001225960 RAY RUSSELL T C/O MERRIMACK PHARMACEUTICALS, INC. ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 1 0 0 0 Stock Option (right to buy) 3.37 2020-07-30 4 A 0 7000 0.00 A 2030-07-29 Common Stock 7000 7000 D This option vests as to 1/4th of the total number of shares on 10/30/20 and an additional 1/4th of the total number of shares at the end of each successive three month period thereafter until 7/30/21, provided that such option shall vest in full on the date that is one business day prior to the date of the issuer's next annual meeting of stockholders (if earlier than 7/30/21). /s/ Russell T. Ray 2020-08-03